Peg-ReliGrast Injection
Marketer
Reliance Life Sciences
Salt Composition
Pegfilgrastim (6mg)
Overview Peg-ReliGrast Injection
Religrast-Peg injection combats infection risk following chemotherapy. This growth factor boosts white blood cell production in the bone marrow, strengthening the body's infection defenses. Administration is via injection by a healthcare professional, continuing as directed by your physician. Treatment length depends on individual needs and response. Regular blood counts and bone density checks may be required during therapy. Common side effects include bone, joint, and muscle pain, headache, and nausea; injection site pain or redness is also frequent. Report persistent lumps, swelling, or bruising at the injection site. While this medication reduces infection risk, fever, chills, breathing difficulties, throat pain, or facial/neck swelling warrant immediate medical attention. Inform your doctor of all other medications you're taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment. Avoid driving or activities requiring alertness if dizziness occurs.
Uses of Peg-ReliGrast Injection
Protecting against infection following chemotherapy treatment
Major Benefits of Peg-ReliGrast Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Peg-ReliGrast Injection:
- Bone pain
- Joint pain
- Headache
- Nausea
- Low blood platelets
- Muscle pain
- Back pain
- Pain in extremities
- Injection site pain
How to use Peg-ReliGrast Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Peg-ReliGrast Injection works:
Peg-ReliGrast Injection is a bone marrow stimulant that boosts the production of infection-fighting white blood cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Peg-ReliGrast Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The safety of Peg-ReliGrast Injection during pregnancy is uncertain. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the risks and advantages before prescribing this medication. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Peg-ReliGrast via injection is likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Peg-ReliGrast Injection.
KidneySAFE IF PRESCRIBED
Peg-ReliGrast Injection presents no safety concerns for use in individuals with impaired renal function. No alteration of the Peg-ReliGrast Injection dosage is necessary.
LiverCONSULT YOUR DOCTOR
Data on Peg-ReliGrast Injection use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Peg-ReliGrast Injection :
Omit a Peg-ReliGrast Injection dose? Seek your physician's advice.
Facts to Know About Peg-ReliGrast Injection
| Label | Value |
|---|---|
| Chemical Category | Granulocyte colony-stimulating factor |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
| Action Class | G-CSF (granulocyte colony-stimulating factor) |
3,018 People bought this recently